Article Details

Teclistamab Shows High MRD Negativity Rates but Raises Safety Concerns in Frontline ...

Retrieved on: 2025-09-19 16:03:31

Tags for this article:

Click the tags to see associated articles and topics

Teclistamab Shows High MRD Negativity Rates but Raises Safety Concerns in Frontline .... View article details on hiswai:

Excerpt

Teclistamab, a bispecific antibody therapy, has shown encouraging ... Monoclonal Antibodies Market to Reach $3.06 Billion by 2030 with 12.4 ...

Article found on: www.geneonline.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo